![Jonathan Symonds](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Symonds
Vorsitzender bei
GSK PLC
Vermögen: 2 Mio $ am 31.05.2026
Profil
Der Gründer des Oxford University Centre for Business Taxation, Jonathan Richard Symonds, ist ein britischer Geschäftsmann, der 8 verschiedene Unternehmen geleitet hat und Non-Executive Chairman bei GlaxoSmithKline Plc und Chairman bei Proteus Digital Health, Inc. ist. Herr Symonds ist auch im Vorstand von Genomics England Ltd. (ehemaliger Vorsitzender), Rubius Therapeutics, Inc. und Harrow School sowie Head-Corporate Finance & Strategy bei Mesoblast Ltd. Zuvor war er Chairman bei The 100 Group, Chairman-Supervisory Board bei Innocoll Holdings Plc Chairman bei Innocoll, Inc. und Chairman-Supervisory Board bei Innocoll AG (beides Tochtergesellschaften von Innocoll Holdings Plc), Chief Financial Officer bei AstraZeneca Plc und Director-Finance bei Zeneca Group Plc (eine Tochtergesellschaft von AstraZeneca Plc), Chief Financial Officer bei Novartis AG, Managing Director bei The Goldman Sachs Group, Inc, Direktor beim Accounting Standards Board, Vorsitzender bei HSBC Bank Plc und Partner bei KPMG LLP (Kanada). Jonathan Richard Symonds erwarb einen Bachelor-Abschluss an der University of Hertfordshire.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GSK PLC 0% | 20.03.2026 | 94’007 ( 0% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Jonathan Symonds
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Vorsitzender | 01.09.2019 |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Direktor/Vorstandsmitglied | 01.11.2019 |
European Round Table For Industry | Corporate Officer/Principal | - |
Harrow School
 Harrow School Miscellaneous Commercial ServicesCommercial Services Operates as independent boarding school | Direktor/Vorstandsmitglied | - |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jonathan Symonds
| Unternehmen | Position | Ende |
|---|---|---|
| RUBIUS THERAPEUTICS | Direktor/Vorstandsmitglied | 27.02.2023 |
| HSBC HOLDINGS PLC | Direktor/Vorstandsmitglied | 18.02.2020 |
HSBC Bank Plc
 HSBC Bank Plc Major BanksFinance Provides commercial and online banking services | Vorsitzender | 01.08.2018 |
Berg LLC
 Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | 01.07.2017 |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jonathan Symonds
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
26
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 26 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Diageo Plc
 Diageo Plc Beverages: AlcoholicConsumer Non-Durables Produces, distributes and sells wine, beer and other beverages | Consumer Non-Durables |
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
HSBC Holdings Plc
 HSBC Holdings Plc Major BanksFinance Operates as a bank holding company with interest in providing national banking services | Finance |
HSBC Bank Plc
HSBC Bank Plc Major BanksFinance Provides commercial and online banking services | Finance |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine products and therapeutic devices | Health Technology |
QinetiQ Group plc
 QinetiQ Group plc Aerospace & DefenseElectronic Technology Provides technology development and consultancy services to the defense, security and related markets | Electronic Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
KPMG LLP (Canada)
 KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Accounting Standards Board | |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products and medical devices | Health Technology |
Oxford University Centre for Business Taxation | |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Commercial Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The 100 Group
 The 100 Group Miscellaneous Commercial ServicesCommercial Services Engages in development of business | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Harrow School
Harrow School Miscellaneous Commercial ServicesCommercial Services Operates as independent boarding school | Commercial Services |
Felix Pharmaceuticals Pvt Ltd.
 Felix Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic (o-patent) medicines for companion animals | Health Technology |
European Round Table For Industry |
